Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alina S. Erokhova"'
Autor:
Inna V. Dolzhikova, Amir I. Tukhvatulin, Daria M. Grousova, Ilya D. Zorkov, Marina E. Komyakova, Anna A. Ilyukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Andrey G. Botikov, Ekaterina G. Samokhvalova, Dmitrii A. Reshetnikov, Andrey E. Siniavin, Daria M. Savina, Dmitrii V. Shcheblyakov, Fatima M. Izhaeva, Alina S. Dzharullaeva, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaya, Denis I. Zrelkin, Polina P. Goldovskaya, Alexander S. Semikhin, Olga V. Zubkova, Andrey A. Nedorubov, Vladimir A. Gushchin, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1152 (2024)
Background: The SARS-CoV-2 virus continuously acquires mutations, leading to the emergence of new variants. Notably, the effectiveness of global vaccination efforts has significantly declined with the rise and spread of the B.1.1.529 (Omicron) varian
Externí odkaz:
https://doaj.org/article/5ca4e161630e45b996f7587289d1a662
Autor:
Amir I. Tukhvatulin, Ilya V. Gordeychuk, Inna V. Dolzhikova, Alina S. Dzharullaeva, Marina E. Krasina, Ekaterina O. Bayurova, Daria M. Grousova, Anna V. Kovyrshina, Alla S. Kondrashova, Daria V. Avdoshina, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Viktoria V. Illarionova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Andrei G. Botikov, Alina S. Erokhova, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Olga V. Zubkova, Elisaveta A. Tokarskaya, Daria M. Savina, Yulia R. Vereveyko, Anastasiya S. Ungur, Boris S. Naroditsky, Aydar A. Ishmukhametov, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 2229-2247 (2022)
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made over the past two years, SARSCoV-2 virus still continues to cause intolerable health and economical losses. Vaccines are considered the most effective way to prevent i
Externí odkaz:
https://doaj.org/article/8a8e17e744c744cc8415e7fd4b98dfbe
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva, Daria M. Grousova, Anna V. Kovyrshina, Olga V. Zubkova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaia, Denis I. Zrelkin, Fatima M. Izhaeva, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Elisaveta A. Tokarskaya, Natalia A. Nikitenko, Nadezhda L. Lubenets, Elizaveta A. Khadorich, Vladimir A. Gushchin, Svetlana N. Borzakova, Anna V. Vlasova, Ismail M. Osmanov, Valerii V. Gorev, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the immunogenicity and safety of the prime-boost “Sputnik V” vaccine administe
Externí odkaz:
https://doaj.org/article/eccefe49c05d44c496a720e9225bf865
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed vaccines. In an effort to satisfy vaccine demands we developed a new single-dose va
Externí odkaz:
https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d
Autor:
Alina S. Dzharullaeva, Amir I. Tukhvatulin, Alina S. Erokhova, Alina S. Bandelyuk, Nikita B. Polyakov, Andrey I. Solovyev, Natalia A. Nikitenko, Dmitry V. Shcheblyakov, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Induction of a robust and long-lived mucosal immune response during vaccination is critical to achieve protection against numerous pathogens. However, traditional injected vaccines are generally poor inducers of mucosal immunity. One of the effective
Externí odkaz:
https://doaj.org/article/d35ea02504f645889a1b12906d5be7da
Autor:
A. I. Tukhvatulin, Denis Y. Logunov, Alina S. Erokhova, Alexander L. Gintsburg, Boris S. Naroditsky, Alina S. Dzharullaeva, Dmitry Scheblyakov
Publikováno v:
Journal of Inflammation Research. 13:357-368
Purpose Pathogens consist of a wide variety of evolutionarily conserved molecular structures that are recognized by pattern recognition receptors (PRRs) of innate immunity. Reasonably assuming that no single PRR is ever likely to be the sole trigger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e71a5c3855129a1d5a6ee98bb274a7a0
https://doi.org/10.2147/jir.s245638
https://doi.org/10.2147/jir.s245638
Autor:
D. A. Kleymenov, Anna V. Kovyrshina, Nadezhda L. Lubenets, Natalia A. Nikitenko, Sergei V. Borisevich, Alexander S. Semikhin, Elizaveta A. Tokarskaya, Daria M. Grousova, Andrey Pochtovyi, M M Shmarov, Dmitry V. Shcheblyakov, Olga Popova, Shchetinin Am, Tatiana A Ozharovskaya, Andrey Komissarov, Evgeniia N. Bykonia, Alina S. Dzharullaeva, Dmitry Lioznov, Alexander L. Gintsburg, Artem P. Tkachuk, A. I. Tukhvatulin, Denis Y. Logunov, Nadezhda P. Kuznetsova, Liubov I. Popova, Olga V. Zubkova, Inna V. Dolzhikova, Lyudmila Vasilchenko, Elena V. Shidlovskaya, Alina S. Erokhova, E. P. Mazunina, Boris S. Naroditsky, Alexander Tsybin, Elizaveta V. Divisenko, Vladimir A. Gushchin, Daria Danilenko, Fatima M. Izhaeva
ObjectivesVaccination remains the most effective response to the COVID-19 pandemic. Most vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, since, on the one hand, they simplify the vaccination program, make it mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f145807fe93e4a55dadded1a8a6b758
https://doi.org/10.1101/2021.10.08.21264715
https://doi.org/10.1101/2021.10.08.21264715
Autor:
Olga V. Zubkova, T A Ozharovskaia, Daria M. Grousova, Boris S. Naroditsky, D N Scherbinin, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Loginova Sy, A S Gromova, Alina S. Dzharullaeva, Alexander L. Gintsburg, Olga Popova, Denis Y. Logunov, Maxim M. Shmarov, A. I. Tukhvatulin, Borisevich Sv, Alina S. Erokhova
Publikováno v:
Acta Naturae. 11:38-47
The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 during the first Middle East respiratory syndrome (MERS) outbreaks. MERS-CoV causes an acute lower-respiratory infection in humans, with a fatality rate of ~35.5%. Cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58bf3f2572e964567a84e6dcd0f561a2
https://doi.org/10.32607/20758251-2019-11-1-38-47
https://doi.org/10.32607/20758251-2019-11-1-38-47
Autor:
A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
SSRN Electronic Journal.
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by obvious shortage in supply of licensed vaccines. Development of new vaccines that are easy to manufacture and administer is highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46dd4f7e36c0425bc50de16bb4665594
https://doi.org/10.2139/ssrn.3886430
https://doi.org/10.2139/ssrn.3886430